ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026
[Effect of TVT-Abbrevo in the treatment of female stress urinary incontinence].
Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the efficacy of tension-free vaginal tape-Abbrevo (TVT-Abbrevo, TVT-A) in the treatment of female stress urinary incontinence (SUI).
methodsA retrospective analysis was conducted on patients who underwent TVT-A surgery for SUI in the Department of Obstetrics and Gynecology of Peking University First Hospital from April 2014 to December 2021. Perioperative data were collected, and various questionnaire scores were obtained from the patients before and after the operation, including the International Consultation on Incontinence questionnaire-short form (ICI-Q-SF), the pelvic organ prolapse/urinary incontinence sexual questionnaire-12 (PISQ-12), and the incontinence quality of life questionnaire (I-QOL). A 1-hour pad test was also performed. The efficacy of TVT-A and its impact on the patients' postoperative quality of life and sexual life were analyzed.
resultsIn this comprehensive study, a total of 130 patients with SUI underwent TVT-A, among whom 111 patients completed the follow-up. The median age of the patients was 60 (51, 66) years, and the median follow-up time was 58.5 (15-105) months. Among the 111 patients, for the 10 patients who solely received TVT-A, the operative duration was (32.25±8.75) min, and the blood loss volume was (12.75±8.48) mL. No intraoperative complications occurred in the 111 patients. Among the postoperative complications, groin pain (8 cases, 7.2%) was the most common, followed by new-onset urinary frequency and urgency (11 cases, 9.9%) and urinary tract infection (4 cases, 3.6%). There were no cases of dysuria, sling erosion, or persistent groin pain. Subjectively, 106 cases (95.5%) were cured and 5 cases (4.5%) were relieved; Objectively, 109 cases (98.2%) were cured and 2 cases (1.8%) were relieved. The ICI-Q-SF scores before and after the operation were 16.00 (11.00, 19.00) and 0.00 (0.00, 5.00), respectively; the PISQ-12 scores were (11.49±3.86) and (13.91±3.96), respectively; and the total I-QOL scores (involving behavioral limitations, psychological impact, and social impairment) were (84.19±15.36) and (106.36±8.93), respectively. All scores improved significantly after the operation compared with those before the operation (
conclusionTVT-A has fewer intraoperative and postoperative complications, and it has a good therapeutic effect on female SUI. Compared with TVT-obturator, the incidence of groin pain after surgery is lower, which can significantly improve the quality of life and sexual life of the patients.
Indexed as
Identifiers
41978405PMC13077334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.